Dr Balram Bharagava, Director General, Indian Council of Medical Research ... - Latest Tweet by IANS India

Dr Balram Bharagava, Director General, Indian Council of Medical Research (@ICMRDELHI) said that the Molnupiravir drug is not included in the national #Covid taskforce treatment as it has major safety concerns like teratogenicity, mutagenicity, muscle & bone damage among others. pic.twitter.com/fOIwzsM76u— IANS Tweets (@ians_india) January 5, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)